Coherus BioSciences is now heavily focused on developing its pipeline, particularly casdozokitug and CHS-114. See why I rate ...

Despite macroeconomic risks, Flagstar Financial's current market price near $10 offers an attractive discount to TBV, with ...

Exemption from the $5.1 million repayment obligation strengthens LAVA’s balance sheetUnderscores focus on cost curtailment and strategic option ...

Community Capital Technology ("Community Capital"), the premier digital loan marketplace, and Participate (a BankLabs Innovation), a leader in loan participation and syndication automation, today ...

This commitment to capital returns has been well-received by the market, as evidenced by a 5% increase in share price following the announcement of balance sheet optimization plans in late 2024.

This commitment to capital returns has been well-received by the market, as evidenced by a 5% increase in share price following the announcement of balance sheet optimization plans in late 2024.

We also estimate the bank will incur around CAD 2.5 billion in costs in 2025 from its US balance sheet repositioning. We expect TD to average around 3.5% annual loan growth over the next five ...

Tilray Brands, Inc. (“Tilray” or “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of beverage, cannabis and wellness industries, today ...